“Brain-Specific” Nutrients: A Memory Cure?

Abstract

We review the experimental evaluations of several widely marketed nonprescription compounds claimed to be memory enhancers and treatments for age-related memory decline. We generally limit our review to double-blind placebo-controlled studies. The compounds examined are phos-phatidylserine (PS), phosphatidylcholine (PC), citicoline, piracetam, vinpocetine, acetyl-L-carnitine (ALC), and antiox-idants (particularly vitamin E). In animals, PS has been shown to attenuate many neuronal effects of aging, and to restore normal memory on a variety of tasks. Preliminary findings with humans, though, are limited. For older adults with probable Alzheimer's disease, a single study failed to demonstrate positive effects of PS on memory performance. For older adults with moderate cognitive impairment, PS has produced consistently modest increases in recall of word lists. Positive effects have not been as consistently reported for other memory tests. There is one report of consistent benefits across a number of memory tests for a subset of normal adults who performed more poorly than their peers at baseline. The choline compounds PC and citicoline are thought to promote synthesis and transmission of neurotransmitters important to memory. PC has not proven effective for improving memory in patients with probable Alzheimer's disease. The issue remains open for older adults without serious degenerative neural disease. Research on citicoline is practically nonexistent, but one study reported a robust improvement in story recall for a small sample of normally aging older adults who scored lower than their peers in baseline testing. Animal studies suggest that piracetam may improve neuronal efficiency, facilitate activity in neurotransmitter systems, and combat the age-related decrease in receptors on the neuronal membrane. However, for patients with probable Alzheimer's disease, as well as for adults with age-associated memory impairment, there is no clear-cut support for a mnemonic benefit of piracetam. Vinpocetine increases blood circulation and metabolism in the brain. Animal studies have shown that vinpocetine can reduce the loss of neurons due to decreased blood flow. In three studies of older adults with memory problems associated with poor brain circulation or dementia-related disease, vinpocetine produced significantly more improvement than a placebo in performance on global cognitive tests reflecting attention, concentration, and memory. Effects on episodic memory per se have been tested minimally, if at all. ALC participates in cellular energy production, a process especially important in neurons, and in removal of toxic accumulation of fatty acids. Animal studies show that ALC reverses the age-related decline in the number of neuron membrane receptors. Studies of patients with probable Alzheimer's disease have reported nominal advantages over a range of memory tests for ALC-treated patients relative to placebo groups. Significant differences have been reported rarely, however. Whether ALC would have mnemonic benefits for ...

Cellular Stress Response: A Novel Target for Chemoprevention and Nutritional Neuroprotection in Aging, Neurodegenerative Disorders and Longevity

“…The main mechanism of action of ALC is the improvement of mitochondrial respiration which allows the neuron to produce ATP necessary to maintain the normal membrane potential [251]. However, ALC has been shown to be neuroprotective through a variety of other effects such as the increase in PKC activity [251].…”

“…The main mechanism of action of ALC is the improvement of mitochondrial respiration which allows the neuron to produce ATP necessary to maintain the normal membrane potential [251]. However, ALC has been shown to be neuroprotective through a variety of other effects such as the increase in PKC activity [251]. Interestingly ALC counteracted the loss of NMDA receptors in neuronal membrane and increased the production of neurotrophins, two effects strictly related to synaptic plasticity [251].…”

“…However, ALC has been shown to be neuroprotective through a variety of other effects such as the increase in PKC activity [251]. Interestingly ALC counteracted the loss of NMDA receptors in neuronal membrane and increased the production of neurotrophins, two effects strictly related to synaptic plasticity [251]. Recent studies have shown that ALC reduces Ab toxicity in primary cortical neuronal cultures by increasing both HO-1 and Hsp70 expression [252].…”

Daily consumption of green tea catechin delays memory regression in aged mice

“…Neuroprotective dietary components have an essential role in facilitating healthy ageing of the brain (Devi and Kiran 2004;Joseph et al 2005). Dietary antioxidants from fruits and vegetables have preventative effects on oxidative stress (Bastianetto and Quirion 2002;Esposito et al 2002;Galli et al 2002;McDaniel et al 2003;Schmitt-Schillig et al 2005;Youdim et al 2002). Green tea catechin (GT-catechin) is a mixture of plant polyphenols that have potent antioxidative and radical-scavenging activities (Kashima 1999;Kimura et al 2002;Levites et al 2001;Nanjo et al 1999;Skrzydlewska et al 2002;Suzuki et al 2004;Terao 1999).…”

Zinc status, psychological and nutritional assessment in old people recruited in five European countries: Zincage study

“…It is well known that some psychological dimensions, such as cognitive performances, mood and the perceived stress may change or decrease in ageing, particularly from the age of 60 years (McDaniel et al 2003;Marcellini et al 2006). It has been suggested that mood disorders and depressive status may be accompanied by lowered serum zinc concentrations (Maes et al 1999), which lead to frailty, general disability and increased incidence of agerelated degenerative diseases .…”